Michael Valerio
Family · Greenville, SCNPI 1487372512
Payments from drug & device makers
Across 121 payments — averaging $18.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$298
- Novo Nordisk$251
- Merck$223
- Novartis$210
- Amgen$151
- AstraZeneca$135
- plus $998 from 18 others
What the payments were for
- Food & beverage$2,265100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 26 | $298 |
| Novo Nordisk | 13 | $251 |
| Merck | 9 | $223 |
| Novartis | 8 | $210 |
| Amgen | 8 | $151 |
| AstraZeneca | 8 | $135 |
| Exact Sciences | 7 | $121 |
| Bayer | 5 | $91 |
| Lilly USA, LLC | 5 | $89 |
| AbbVie | 4 | $88 |
| Viiv Healthcare Company | 3 | $84 |
| Boehringer Ingelheim | 4 | $83 |
| E.r. Squibb & Sons, L.L.C. | 4 | $71 |
| Alnylam Pharmaceuticals Inc. | 3 | $67 |
| Philips North America LLC | 2 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| Abiomed | 2 | $46 |
| Theratechnologies Inc. | 1 | $35 |
| Boston Scientific | 1 | $24 |
| ZOLL Medical Corporation | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Impulse Dynamics (USA) Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $14 |
| GSK | 1 | $14 |
How this compares
$2,265 in reported general payments places this provider in the 80th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 27 | $28,369 |
| JardianceEmpagliflozin | 17 | $16,566 |
| OzempicSemaglutide | 12 | $12,168 |
| Xigduo XrDapaglifloz Propaned/Metformin | 17 | $10,287 |
| Duloxetine Hcl | 19 | $835 |
| Gabapentin | 33 | $742 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $346 |
| Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med | 14 | $339 |
| Fluticasone Propionate | 20 | $248 |
| Atorvastatin Calcium | 37 | $214 |
| Quetiapine Fumarate | 13 | $178 |
| Rosuvastatin Calcium | 11 | $171 |
| Losartan Potassium | 25 | $162 |
| Metformin Hcl ErMetformin Hcl | 25 | $145 |
| Levothyroxine Sodium | 17 | $139 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $89 | $28,36927 claims |
| Boehringer IngelheimJardiance | $83 | $16,56617 claims |
| Novo NordiskOzempic | $251 | $12,16812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,248 family providers in South Carolina.
Other family in Greenville
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Carrie HendersonGreenville$91K
- Michelle StrongGreenville$55K
- Melissa BrownlowGreenville$20K
- Sarah McNightGreenville$15K
- Melissa MotesGreenville$13K
- Matthew KeatonGreenville$10K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.